NRX Therapeutics

NRXP

3.3305.93% ( -0.210 )

Trading: Jul 29, 14:29:13 (EDT)

Q1 FY2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Preview: NRX Therapeutics(NRXP) predict that the Revenue is 1.068 M (--%), Miss estimate;the EBIT is -4.742 M (-23.26%), Miss estimate;the EPS is -0.04 (+88.24%), Miss estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueMiss expectations

0.00B--

0.02B--

-0.02B--%

EBITMiss expectations

-0.00B23.26%

0.01B320.46%

-0.01B343.72%

EPSMiss expectations

-0.0488.24%

0.208161.18%

-0.248072.94%

Revenue

ActualEstimateUnit: USD

EBIT

ActualEstimateUnit: USD

Net income

ActualEstimateUnit: USD

EPS

ActualEstimateUnit: USD